Vertex Pharmaceuticals
VRTX
$404.91
Share price
1.25%
Change (1 day)
21.65%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Cash on Hand
Cash on Hand as of December 2023 : $11.21 B
According to Vertex Pharmaceuticals's latest financial reports the company has $11.21 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vertex Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $11.21 B | 4.08% |
| 2022-12-31 | $10.77 B | 43.24% |
| 2021-12-31 | $7.52 B | 13.01% |
| 2020-12-31 | $6.65 B | 74.85% |
| 2019-12-31 | $3.80 B | 20.2% |
| 2018-12-31 | $3.16 B | 51.69% |
| 2017-12-31 | $2.08 B | 45.6% |
| 2016-12-31 | $1.43 B | 37.61% |
| 2015-12-31 | $1.04 B | -24.85% |
| 2014-12-31 | $1.38 B | -5.32% |
| 2013-12-31 | $1.46 B | 10.89% |
| 2012-12-31 | $1.32 B | 36.36% |
| 2011-12-31 | $0.96 B | -6.06% |
| 2010-12-31 | $1.03 B | -19.73% |
| 2009-12-31 | $1.28 B | 54.42% |
| 2008-12-31 | $0.83 B | 80.55% |
| 2007-12-31 | $0.46 B | -34.59% |
| 2006-12-31 | $0.70 B | 95.1% |
| 2005-12-31 | $0.36 B | -6.5% |
| 2004-12-31 | $0.38 B | -33.77% |
| 2003-12-31 | $0.58 B | -8.16% |
| 2002-12-31 | $0.63 B | -14.56% |
| 2001-12-31 | $0.74 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 104.37% | 🇺🇸 USA |
 AbbVie ABBV | $12.81 B | 14.24% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.26 B | -35.25% | 🇺🇸 USA |
 Merck MRK | $7.09 B | -36.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 9.46% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.33 B | -96.99% | 🇺🇸 USA |